Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances towards natural plants as potential inhibitors of SARS-Cov-2 targets
Zhouman He, Jia Yuan, Yuanwen Zhang, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 1186-1210
Open Access | Times Cited: 11

Showing 11 citing articles:

Structure-Based Discovery of the SARS-CoV-2 Main Protease Noncovalent Inhibitors from Traditional Chinese Medicine
Xiaojie Jin, Min Zhang, Beibei Fu, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 4, pp. 1319-1330
Closed Access | Times Cited: 7
Predicting the Anti-SARS-CoV-2 Potential of Isoquinoline Alkaloids from Brazilian Siparunaceae Species Using Chemometric Tools
Brendo Araújo Gomes, Diégina Araújo Fernandes, Simony Carvalho Mendonça, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 633-633
Open Access
Effects of organic salts of virucidal and antiviral compounds from Nelumbo nucifera and Kaempferia parviflora against SARS-CoV-2
Dandan Yang, Nopporn Chutiwitoonchai, Feng Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Dissecting the Molecular Mechanism Concerning Conformational Changes of SARS‐CoV‐2 Main Protease Mediated by Binding of Natural Phytochemicals via Molecular Dynamics Simulations
Chaoyue Jia, Yanqi Sun, Jianzhong Chen, et al.
ChemistrySelect (2025) Vol. 10, Iss. 13
Closed Access
Repurposing of antimycobacterium drugs for COVID-19 treatment by targeting SARS CoV-2 main protease: An in-silico perspective
Ayon Chakraborty, Rajesh Ghosh, Saswati Soumya Mohapatra, et al.
Gene (2024) Vol. 922, pp. 148553-148553
Closed Access | Times Cited: 3
Novel Papain-Like Protease Inhibitors for Treating Viral Infections, in particular, Coronavirus Infections
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1186-1187
Closed Access | Times Cited: 3
In vitro cytotoxicity and antiviral activity of aminocaproic acid against SARS-CoV-2
Timur Saliev, Shynar Tanabayeva, Neilya Ussebayeva, et al.
Journal Of Advanced Pharmacy Education And Research (2024) Vol. 14, Iss. 3, pp. 1-8
Closed Access | Times Cited: 1
Unlocking the therapeutic potential of edible mushrooms: Ganoderma and their secondary metabolites as novel antiviral agents for combating COVID-19
Samantha C. Karunarathna, Wenhua Lu, Nimesha Patabedige, et al.
New Zealand Journal of Botany (2024), pp. 1-59
Closed Access | Times Cited: 1
Diosmetin-7-O-β-D-glucopyranoside from Pogostemonis Herba alleviated SARS-CoV-2-induced pneumonia by reshaping macrophage polarization and limiting viral replication
Yunlu Xu, Xuejian Li, Wei Cai, et al.
Journal of Ethnopharmacology (2024) Vol. 336, pp. 118704-118704
Closed Access | Times Cited: 1
Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula
Wei‐Jan Wang, Hsuan-Ting Tang, Shi‐Chen Ou, et al.
Cancer Letters (2024) Vol. 604, pp. 217198-217198
Closed Access | Times Cited: 1
AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors
Ioannis Gkekas, Sotirios Katsamakas, Stelios K. Mylonas, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 22, pp. 8562-8585
Open Access
Page 1

Scroll to top